GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » YoY EBITDA Growth

Acrobiosystems Co (SZSE:301080) YoY EBITDA Growth : -31.63% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Acrobiosystems Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -31.63%.

Acrobiosystems Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.27.


Acrobiosystems Co YoY EBITDA Growth Historical Data

The historical data trend for Acrobiosystems Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co YoY EBITDA Growth Chart

Acrobiosystems Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial - - -16.07 54.86 -18.59

Acrobiosystems Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.37 -17.25 -35.18 -27.65 -31.63

Acrobiosystems Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Acrobiosystems Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(1.712-2.103)/ | 2.103 |
=-18.59 %

Acrobiosystems Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.268-0.392)/ | 0.392 |
=-31.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acrobiosystems Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrobiosystems Co (SZSE:301080) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co (SZSE:301080) Headlines

No Headlines